Kathryn Stephenson, MD, MPH (Center for Virology and Vaccine Research, BIDMC) shared how the impact of low vaccination levels can be significant for long-term public health for two reasons: first, pockets of ongoing infection in one community can be a source for new outbreaks in all communities in the future; second, it can significantly exacerbate already stark health disparities between communities.

The impact of the anti-vaxx movement: What happens if only half the country gets the Covid vaccine?

Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC) spoke to whether COVID-19 could evolve to render the current vaccine ineffective.

Don’t worry about the mutation — yet

Sharon Wright, MD, MPH (Infectious Disease, BILH) discussed whether the current COVID-19 vaccines are effective against the new strain.

Boston infectious disease expert shares latest on new strain of coronavirus

Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC), lead researcher on the Johnson & Johnson COVID-19 vaccine candidate, said the vaccine in development offers the potential of a single shot vaccine and that not needing subzero freezing will be an advantage for certain parts of the U.S. but will be a vast advantage for the developing world.

Johnson & Johnson Takes Big Step Forward With Its Vaccine Trial, Has Potential to Be Single Shot

Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC) shared how the COVID-19 experience will almost certainly change the future of vaccine science.

The lightning-fast quest for COVID vaccines — and what it means for other diseases

Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC) spoke to whether taking more than one type of COVID-19 vaccine is better for boosting immunity against the virus.

Should people take more than one type of COVID-19 vaccine?

The New York Times detailed how the Johnson & Johnson and BIDMC COVD-19 vaccine candidate works. The vaccine is being developed in collaboration between Johnson & Johnson and BIDMC, led by Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC).

How the Johnson & Johnson Vaccine Works

As millions of the Pfizer and Moderna COVID-19 vaccines are expected to be distributed before year’s end, Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC) says these two vaccines alone are not enough for rapid distribution in the U.S. and certainly not globally.

More vaccines need authorization to inoculate all Americans

This front page story and companion video follow the arrival of the Pfizer/BioNTech vaccine to BIDMC, featuring the perspectives of BILH and BIDMC leaders as well as patient-facing staff who received the vaccine.

Vaccinations boost spirits at hospitals throughout Ma...